Position in DGX
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$7,302,313
+$1,253,979 QoQ
Shares Held
34,453
+11.6% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#195
of 1,096 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DGX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026TCW GROUP INC holds $100,510,843 across 14 Diagnostics & Research names. DGX ranks #4 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
108,951 | $57,356,163 | |
| 2 | GRAL |
GRAIL, Inc.
|
191,913 | $13,101,900 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
6,093 | $7,783,868 | |
| 4 | DGX |
Quest Diagnostics Inc
This page
|
34,453 | $7,302,313 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
6,255 | $3,136,006 | |
| 6 | CRL |
Charles River Laboratories International, Inc.
|
13,230 | $3,000,431 | |
| 7 | DHR |
Danaher Corp /De/
|
15,107 | $2,877,581 | |
| 8 | FLGT |
Fulgent Genetics, Inc.
|
131,400 | $2,696,328 |
All Filings in DGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,302,313 | 34,453 | Shares | Defined | 2026-08-03 | |
| 2026-03-31 | $6,048,334 | 30,862 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $4,981,698 | 28,708 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,065,044 | 26,577 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,566,193 | 19,853 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,602,634 | 15,382 | Shares | Defined | 2025-05-07 | |
| No filing history on record for this holder in this stock. | ||||||